contraindications for glp 1 agonists Using information from the NPF Medical Board's publication in JAMA Dermatology GLP-1 Receptor Agonists: antidiabetic and

Semaglutide at the 2.4mg weekly dose produced 13.7 percent body weight loss at 72 weeks in the STEP 1 trial

Breathe deeply

While this might seem like a positive outcome, it actually reflects the body's attempt to conserve water in response to reduced intake.The researchers concluded that " GLP-1 receptor agonists reduce fluid intake and thirst perception in patients with primary polydipsia and could therefore be a treatment option for these patients"

Its not just that I was less hungryit felt like a switch had flipped in my brain, the same switch that drives addictive behaviors

50 Lixisenatide Drugs and Lactation Database (2023)

doi: 10.1017/S0007114510001327